Rental and operating of own or leased real estate
LAVOLD INVEST AS
Revenue 2024
NOK 664,000
Operating profit
NOK −890,000
Equity
NOK 71.5m
Incorporated
2005
Share capital
NOK 249,000
Roles
Daglig lederChrister Lavold
Regnskapsfører
Revisor
Styrets lederChrister Lavold
StyremedlemAdele Marlen Tårnes
Auditor
Audit firm
REVISORKOMPANIET TROMSØ AS
4 registrerte revisorer ved REVISORKOMPANIET TROMSØ AS:
CHRISTINA ELIASSENStatsautorisert revisor
HANS MARTIN VAENGStatsautorisert revisor
KIRSTEN ANDBERGStatsautorisert revisor
RONALD SEGLSTENStatsautorisert revisor
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| CHRISTER LAVOLD | 100.0% | 1243000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| SCANDIDERMA AS | Active | 2.1% | 5000.000000 |
| PHARMASUM THERAPEUTICS AS | Active | 0.0% | 406.000000 |
| LYTIX BIOPHARMA ASA | Active | 0.0% | 7640.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.